Efficacy and tolerability after 24 weeks of treatment with telaprevir, pegylated interferon and ribavirin in cirrhotic HIV-HCV coinfected subjects

Efficacy and tolerability of telaprevir, pegylated interferon and ribavirin combination was assessed in 32 cirrhotic genotype 1 hepatitis C (HCV)-HIV coinfected patients. Undetectability of HCV-RNA was observed in 23/32 (71.9%) patients after 24 weeks. Treatment failure was observed in 9/32 subjects...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Antiviral research 2014-04, Vol.104, p.59-61
Hauptverfasser:	GENEBAT, Miguel, VERA, Francisco, MARINO, Ana, LLUCH, José F, MARTINEZ-PEREZ, María A, MARIN, Jorge, RUIZ-MATEOS, Ezequiel, LEAL, Manuel, HERNANDEZ-QUERO, José, DOMINGO, Pere, GUARDIOLA, José M, MARTINEZ-MADRID, Onofre, MARTINEZ, Lorena, GARCIA DE LA LLANA, Francisco, SANCHEZ-VILLEGAS, Jorge, ALVAREZ, Hortensia
Format:	Artikel
Sprache:	eng
Schlagworte:	Adolescent Adult Aged Antibiotics. Antiinfectious agents. Antiparasitic agents Antiviral agents Antiviral Agents - adverse effects Antiviral Agents - therapeutic use Biological and medical sciences Coinfection - drug therapy Drug Therapy, Combination Female Gastroenterology. Liver. Pancreas. Abdomen Hepatitis C, Chronic - drug therapy Hepatitis C, Chronic - pathology Hepatitis C, Chronic - virology HIV Infections - drug therapy HIV Infections - pathology HIV Infections - virology Human viral diseases Humans Infectious diseases Interferons - administration & dosage Liver Cirrhosis - pathology Liver. Biliary tract. Portal circulation. Exocrine pancreas Male Medical sciences Middle Aged Oligopeptides - administration & dosage Other diseases. Semiology Pharmacology. Drug treatments Ribavirin - administration & dosage Time Factors Treatment Outcome Viral diseases Viral diseases of the lymphoid tissue and the blood. Aids Viral hepatitis Viral Load Young Adult
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!